HIV New Product Introduction Toolkit

CHAI developed these frequently asked questions (FAQs) to lay out information for communities and PLHIV on the subject of DRV/r (400/50...

A presentation with the latest information on DRV/r (400/50mg) and considerations for adult second line treatment optimization.

CHAI developed these frequently asked questions (FAQs) to lay out information for national HIV programs considering the adoption and...

CHAI's TLD resources help countries in creating the best plan for TLD introduction. CHAI TLD Clinical Action Memo CHAI DTG Use In Women...